Brief: Processa Pharmaceuticals Announces Successful Phase 2 Meeting With FDA For Next Generation Capecitabine

Processa Pharmaceuticals

13/12/2023 14:08

Dec 13 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS ANNOUNCES SUCCESSFUL PHASE 2
MEETING
WITH FDA FOR NEXT GENERATION CAPECITABINE
    * PROCESSA PHARMACEUTICALS INC:  ENROLLMENT FOR NGC-CAP
PHASE 2
STUDY ANTICIPATED TO BEGIN IN MID-2024

Source text for Eikon:  ID:nGNX8QXKbN 
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))